Detalhe da pesquisa
1.
Acquired non-thermal plasma resistance mediates a shift towards aerobic glycolysis and ferroptotic cell death in melanoma.
Drug Resist Updat
; 67: 100914, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36630862
2.
The potential and controversy of targeting STAT family members in cancer.
Semin Cancer Biol
; 60: 41-56, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31605750
3.
Targeting the PD-1 Axis with Pembrolizumab for Recurrent or Metastatic Cancer of the Uterine Cervix: A Brief Update.
Int J Mol Sci
; 22(4)2021 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33670397
4.
Cetuximab-induced natural killer cell cytotoxicity in head and neck squamous cell carcinoma cell lines: investigation of the role of cetuximab sensitivity and HPV status.
Br J Cancer
; 123(5): 752-761, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32541873
5.
IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts.
J Hematol Oncol
; 17(1): 8, 2024 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38331849
6.
One-step CRISPR-Cas9-mediated knockout of native TCRαß genes in human T cells using RNA electroporation.
STAR Protoc
; 4(1): 102112, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36853667
7.
Establishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity.
Cancer Drug Resist
; 6(4): 709-728, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38239393
8.
The CD70-CD27 axis in oncology: the new kids on the block.
J Exp Clin Cancer Res
; 41(1): 12, 2022 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34991665
9.
The prognostic impact of the immune signature in head and neck squamous cell carcinoma.
Front Immunol
; 13: 1001161, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36268020
10.
The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab via Combination With Natural Killer Cell Chartering Immunotherapeutic Strategies.
Front Immunol
; 12: 737311, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34557197
11.
Immuno-PET Molecular Imaging of RANKL in Cancer.
Cancers (Basel)
; 13(9)2021 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33946410
12.
The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3.
Cancers (Basel)
; 13(2)2021 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33466653
13.
A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy.
J Exp Clin Cancer Res
; 40(1): 213, 2021 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34172082
14.
Auranofin and Cold Atmospheric Plasma Synergize to Trigger Distinct Cell Death Mechanisms and Immunogenic Responses in Glioblastoma.
Cells
; 10(11)2021 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34831159
15.
Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer.
Redox Biol
; 42: 101949, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33812801
16.
Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer.
Cells
; 9(6)2020 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32560232
17.
Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatment.
Clin Transl Immunology
; 9(8): e1165, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32821382
18.
Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells.
Cancers (Basel)
; 11(10)2019 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31635070
19.
Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress.
Cancers (Basel)
; 10(4)2018 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29690507
20.
Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade.
Oncoimmunology
; 7(3): e1407899, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29399410